Clinical Trials

by | Apr 22, 2022

No chemo yesterday and I am not sure what to think.  The CT scans showed my tumors started growing and wad not reacting to the new chemo protocol.  Our focus is now turning towards clinical trial and hopefully Johns Hopkins will have one.  I should know in a few days. The specific trial will target a KRAS mutation that was identified on one of the biopsies.  There is a drug out there that targets this mutation but it is only approved for non-small cell lung cancer.


Submit a Comment

Your email address will not be published. Required fields are marked *

Please send donations in Tara's memory to:

The Appendix Cancer Pseudomyxoma Peritonei Research Foundation or a charity that is important to you.